Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now


DISEASE PROGRESSION side effect

What is DISEASE PROGRESSION ?
Help Community - Describe Your Side Effect   Search FDA Side Effects   Ask Health Expert   DISEASE PROGRESSION and Recently Reported Side Effects   DISEASE PROGRESSION and 15 most Active Side Effect polls   DISEASE PROGRESSION and featured health surveys   Substances toxic to Health   Recent Hospital reviews   Comments about Side Effects   Hospital Quality reviews   Homecare Quality reviews
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with DISEASE PROGRESSION

ABRAXANE  ACCUTANE  ACETAZOLAMIDE  ACTIVASE  ACTONEL  ACTOPLUS  ACYCLOVIR  ADVAIR  AGGRASTAT  ALDACTONE  ALDURAZYME  ALIMTA  ALISKIREN  ALKERAN  AMANTADINE  AMBISOME  AMMONUL  AMPHOTERICIN  ANCOTIL  ANGIOMAX  ARAVA  AREDIA  ARICEPT  ARIMIDEX  ARIXTRA  AROMASIN  ASMANEX  AUGMENTIN  AVANDIA  AVASTIN  AVONEX  AZATHIOPRINE  BACLOFEN  BENADRYL  BETAMETHASONE  BETASERON  BEVACIZUMAB  BEXXAR  BLEOMYCIN  BONDRONAT  BORTEZOMIB  BUMETANIDE  BUSULFAN  CALCIUM  CAMPTOSAR  CANCIDAS  CAP  CAPECITABINE  CAPHOSOL  CARBOPLATIN  CASODEX  CEFTAZIDIME  CELESTAMINE  CELLCEPT  CEREZYME  CERTICAN  CETUXIMAB  CICLOSPORIN  CILOSTAZOL  CIPROFLOXACIN  CISPLATIN  CLARAVIS  CLEMASTINE  CLIMARA  CLOFARABINE  CLOZAPINE  CLOZARIL  COLACE  COMPAZINE  COMTAN  COPAXONE  CORDARONE  COREG  CORTANCYL  COVIRO  CUBICIN  CYCLOPHOSPHAMIDE CYCLOSPORINE  CYTARABINE  CYTOVENE  CYTOXAN  DACARBAZINE  DACOGEN  DANTROLENE  DASATINIB  DAUNORUBICIN  DECADRON  DECITABINE  DEFERASIROX  DEPOCYT  DEXAMETHASONE  DEXTROSE  DIHYDERGOT  DILAUDID  DIOVAN  DOCETAXEL  DOXIL  DOXORUBICIN  DURAGESIC  DUROTEP  DYSPORT  EFFEXOR  ELAPRASE  ELIDEL  ELISOR  ELOXATIN  ELSPAR  ENBREL  EPIRUBICIN  ERBITUX  ERLOTINIB  ERLOTINIBLET  ETOPOSIDE  EXELON  EXFORGE  EXJADE  FABRAZYME  FAMVIR  FASLODEX  FAZACLO  FEMHRT  FENOFIBRATE  FENTANYL  FENTORA  FLOLAN  FLOMAX  FLORINEF  FLUCONAZOLE  FLUDARABINE  FLUOROURACIL  FOLINIC  FOLLITROPIN  FORADIL  FUNGUARD  FUROSEMIDE  FUZEON  GABAPENTIN  GABITRIL  GEMCITABINE  GEMTUZUMAB  GEMZAR  GLEEVEC  GLIADEL  GLIVEC  GLYBURIDE  GMCSF  HEPARIN  HERCEPTIN  HIGH  HUMIRA  HYCAMTIN  IBUPROFEN  IFOMIDE  IFOSFAMIDE  IMATINIB  IMURAN  INFLIXIMAB  INTERFERON  INTRON  IRESSA  IRINOTECAN  ISENTRESS  ISOTRETINOIN  ITRACONAZOLE  KEPPRA  LAPATINIB  LAPATINIBLET  LENALIDOMIDE  LEUCOVORIN  LEXAPRO  LIALDA  LIDOCAINE  LIORESAL  LIPITOR  LOTREL  LUCENTIS  LYRICA  MABTHERA  MEMANTINE  METHOTREXATE  METHYLPHENIDATE  METRONIDAZOLE  MIGLUSTAT  MILK  MIRAPEX  MITOTANE  MST  MYCAMINE  MYCOPHENOLATE  MYCOPHENOLIC  MYFORTIC  MYLOTARG  MYOZYME  NAGLAZYME  NAMENDA  NATALIZUMAB  NATEGLINIDE  NAVELBINE  NELFINAVIR  NEORAL  NEULASTA  NEVIRAPINE  NEXAVAR  NICARDIPINE  NILOTINIB  NOLVADEX  NOVANTRONE  NOVOSEVEN  NOXAFIL  OMEPRAZOLE  OMNISCAN  ONCASPAR  ONTAK  OXALIPLATIN  OXANDRIN  OXYCONTIN  PACLITAXEL  PACLITAXELECTION PACLITAZELECTION PALLADONE  PAMIDRONATE  PANITUMUMAB  PEGASYS  PEMETREXED  PRAVASTATIN  PREDNISOLONE  PREDNISONE  PROCRIT  PROGRAF  PROPRANOLOL  PROVENTIL  RAD  RANIBIZUMAB  RAPAMUNE  RAPAMYCIN  REBIF  REMICADE  REQUIP  REVLIMIB  REVLIMID  RIFATER  RILUTEK  RITUXAN  RITUXIMAB  ROCEPHIN  ROFERON  ROSIGLITAZONE  SAIZEN  SAMARIUM  SANDIMMUNE  SANDOSTATIN  SCOPODERM  SEBIVO  SERETIDE  SEROQUEL  SERTRALINE  SEVREDOL  SILDENAFIL  SIMETHICONE  SINEMET  SORAFENIB  SPIRIVA  STALEVO  SUDAFED  SUNITINIB  SUTENT  TAMOXIFEN  TARCEVA  TARGRETIN  TASIGNA  TAXOTERE  TEMODAL  TEMODAR  TEMOZOLOMIDE  TEMSIROLIMUS  THALIDOMIDE  THALOMID  THYMOGLOBULIN  TICLOPIDINE  TIKLYD  TISASEN  TOBRADEX  TOPOTECAN  TORASEMIDE  TORISEL  TOSITUMOMAB  TRACLEER  TRASTUZUMAB  TRIAMCINOLONE  TRICIRIBINE  TRIOMUNE  TRISENOX  TYGACIL  TYKERB  TYSABRI  TYVERB  URSODIOL  VAGIFEM  VALCYTE  VALPROIC  VANCOMYCIN  VELCADE  VENTAVIS  VERAMYST  VESICARE  VFEND  VIDAZA  VINCRISTINE  VINORELBINE  VISUDYNE  VITAMIN  VOLTAREN  WARFARIN  WELLBUTRIN  XALATAN  XELODA  XOLAIR  XYREM  ZALCITABINE  ZANTAC  ZAVESCA  ZELNORM  ZEVALIN  ZIDOVUDINE  ZOCOR  ZOLADEX  ZOLEDRONATE  ZOLEDRONIC  ZOMETA  ZONEGRAN  ZYPREXA  ZYVOX  


Sutent Side Effects Report #5649563-9
Physician from AUSTRALIA reported SUTENT problem on Feb 21, 2008. Male patient, weighting 200.6 lb, was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: disease progression, dyspepsia, nausea, oesophagitis, vomiting, . SUTENT dosage: unknown. Patient recovered.

Erlotinib Side Effects Report #5652116-X
ERLOTINIB problem was reported by a Health Professional from JAPAN on Feb 19, 2008. Male patient, 65 years of age, was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: disease progression, hyperkalaemia, . ERLOTINIB dosage: 160 MG, QD, ORAL. During the same period patient was treated with RABEPRAZOLE, ALLOPURINOL, TEGRETOL, METHYCOBAL, OXYCONTIN. Patient died on 01/30/2008.

Revlimid Side Effects Report #5652142-0
Physician from SWITZERLAND reported REVLIMID problem on Feb 25, 2008. Female patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, multiple myeloma, . REVLIMID dosage: unknown. Patient died.

Bondronat Side Effects Report #5655348-X
BONDRONAT problem was reported by a Physician from GERMANY on Feb 25, 2008. Female patient, 57 years of age, was treated with BONDRONAT. After drug was administered, patient experienced the following problems/side effects: disease progression, ill-defined disorder, metastases to bone, . BONDRONAT dosage: unknown. During the same period patient was treated with ZOMETA. Patient was hospitalized. Patient died.


Avastin Side Effects Report #5655964-5
Consumer or non-health professional from UNITED KINGDOM reported AVASTIN problem on Feb 22, 2008. Male patient was diagnosed with rectal cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: disease progression, . AVASTIN dosage: 671 MG, UNK. Patient died on 04/01/2007.

Temodal Side Effects Report #5656219-5
TEMODAL problem was reported by a Consumer or non-health professional from FRANCE on Feb 29, 2008. Female patient, 83 years of age, weighting 136.7 lb, was diagnosed with glioblastoma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: disease progression, glioblastoma, . TEMODAL dosage: 150 MG/M2; ; PO, 200 MG/M2; ; PO. Patient died on 10/10/2007.

Ibuprofen Side Effects Report #5656264-X
Health Professional from GERMANY reported IBUPROFEN problem on Feb 14, 2008. Male patient was diagnosed with pain, infection prophylaxis, hypertension, thrombosis prophylaxis, depression and was treated with IBUPROFEN. After drug was administered, patient experienced the following problems/side effects: disease progression, overdose, polyarthritis, stevens-johnson syndrome, . IBUPROFEN dosage: (1200 MG ORAL). During the same period patient was treated with AUGMENTIN, NOVALGIN, BAYOTENSIN, LOPIRIN, OXYGESIC, REMERGIL, ANTRA. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5657233-6
GEMCITABINE problem was reported by a Physician from UNITED STATES on Mar 07, 2008. Female patient, weighting 114.6 lb, was diagnosed with squamous cell carcinoma and was treated with GEMCITABINE. After drug was administered, patient experienced the following problems/side effects: disease progression, respiratory failure, . GEMCITABINE dosage: 3000 MG/M2 IV Q 2 WEEKS. During the same period patient was treated with DOCETAXEL. Patient died on 02/09/2008.

Sutent Side Effects Report #5657431-1
Physician from AUSTRALIA reported SUTENT problem on Feb 27, 2008. Male patient, weighting 176.4 lb, was diagnosed with renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: disease progression, renal cell carcinoma, . SUTENT dosage: unknown. Patient died.


Mycophenolate Side Effects Report #5657657-7
MYCOPHENOLATE MOFETIL problem was reported by a Physician from UNITED STATES on Feb 29, 2008. Female patient, 67 years of age, weighting 130.1 lb, was diagnosed with heart transplant and was treated with MYCOPHENOLATE MOFETIL. After drug was administered, patient experienced the following problems/side effects: disease progression, hyperglycaemia, pericardial drainage, pericardial effusion, productive cough, troponin increased, vision blurred, . MYCOPHENOLATE MOFETIL dosage: 0.75 MG, BID. During the same period patient was treated with BACTRIM, VALCYTE, PREDNISONE, INSULIN, NEORAL. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #5659498-3
Consumer or non-health professional from DENMARK reported CYCLOPHOSPHAMIDE problem on Mar 07, 2008. Female patient, 60 years of age, weighting 165.3 lb, was diagnosed with metastases to bone and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: disease progression, osteonecrosis, tooth extraction, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with EPIRUBICIN, FLUOROURACIL, ZOMETA. Patient died on 08/11/2007.

Temodal Side Effects Report #5660490-3
TEMODAL problem was reported by a Consumer or non-health professional from FRANCE on Feb 29, 2008. Male patient, 76 years of age, weighting 121.3 lb, was diagnosed with malignant glioma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: disease progression, malignant glioma, . TEMODAL dosage: 150 MG/M2; ; PO, 320 MG; QD; PO. During the same period patient was treated with HYPNOVEL, SCOPOLAMINE, MORPHINE. Patient died on 09/12/2007.

Tamoxifen Side Effects Report #5660886-X
Consumer or non-health professional from UNITED STATES reported TAMOXIFEN problem on Mar 05, 2008. Female patient, 66 years of age, weighting 182.1 lb, was diagnosed with breast cancer and was treated with TAMOXIFEN. After drug was administered, patient experienced the following problems/side effects: disease progression, recurrent cancer, surgery, . TAMOXIFEN dosage: unknown. During the same period patient was treated with ARIMIDEX, PRILOSEC. Patient recovered.

Durotep Side Effects Report #5661364-4
DUROTEP problem was reported by a Physician from JAPAN on Mar 03, 2008. Male patient, 72 years of age, was diagnosed with cancer pain, insomnia, diarrhoea and was treated with DUROTEP. After drug was administered, patient experienced the following problems/side effects: disease progression, . DUROTEP dosage: unknown. During the same period patient was treated with DECADRON, MYSLEE, LOPEMIN, FESIN, ALDACTONE, LASIX. Patient died on 03/01/2008.


Dacarbazine Side Effects Report #5661935-5
Physician from UNITED STATES reported DACARBAZINE problem on Mar 10, 2008. Male patient, weighting 179.9 lb, was diagnosed with malignant melanoma and was treated with DACARBAZINE. After drug was administered, patient experienced the following problems/side effects: disease progression, gastrointestinal haemorrhage, mass, . DACARBAZINE dosage: 1600MG, IV Q21DAYS. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.

Elidel Side Effects Report #5662451-7
ELIDEL problem was reported by a Physician from YUGOSLAVIA on Mar 03, 2008. Female patient, child 8 years of age, was diagnosed with dermatitis atopic and was treated with ELIDEL. After drug was administered, patient experienced the following problems/side effects: disease progression, erythema, pruritus, respiratory tract infection, skin exfoliation, skin tightness, . ELIDEL dosage: unknown. Patient recovered.

Revlimid Side Effects Report #5662862-X
Physician from UNITED STATES reported REVLIMID problem on Feb 29, 2008. Female patient, 71 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, febrile neutropenia, . REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient died on 02/29/2008.

Velcade Side Effects Report #5663524-5
VELCADE problem was reported by a Physician from JAPAN on Mar 05, 2008. Female patient, 70 years of age, weighting 116.8 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: disease progression, platelet count decreased, . VELCADE dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, NOVAMIN, OXYCONTIN, ETODOLAC. Patient died on 12/14/2007.

Rebif Side Effects Report #5664186-3
Physician from UNITED STATES reported REBIF problem on Feb 28, 2008. Female patient, 64 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: disease progression, motor neurone disease, . REBIF dosage: unknown. During the same period patient was treated with NOVANTRONE, CYMBALTA. Patient was hospitalized. Patient died on 04/16/2007.


Revlimid Side Effects Report #5668559-4
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 06, 2008. Male patient, 70 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, myelodysplastic syndrome, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 02/16/2008.

Revlimid Side Effects Report #5668661-7
Physician from UNITED STATES reported REVLIMID problem on Mar 06, 2008. Male patient, 47 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, multiple myeloma, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died.

Sutent Side Effects Report #5669821-1
SUTENT problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 05, 2008. Male patient, weighting 97.00 lb, was diagnosed with metastatic renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: disease progression, metastatic renal cell carcinoma, perirectal abscess, . SUTENT dosage: unknown. During the same period patient was treated with LEVAQUIN, VICODIN, MORPHINE, NYSTATIN, IMODIUM. Patient was hospitalized. Patient died on 10/11/2005.

Avastin Side Effects Report #5670016-6
Physician from CANADA reported AVASTIN problem on Mar 06, 2008. Male patient was diagnosed with colon cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: disease progression, . AVASTIN dosage: unknown. Patient died on 10/01/2007.

Sutent Side Effects Report #5671328-2
SUTENT problem was reported by a Physician from AUSTRALIA on Mar 07, 2008. Male patient, weighting 154.3 lb, was diagnosed with renal cell carcinoma, constipation, fatigue, wound infection, pain, gastrooesophageal reflux disease, candidiasis and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: disease progression, renal cell carcinoma, . SUTENT dosage: unknown. During the same period patient was treated with MOVICOL, DEXAMETHASONE, VANCOMYCIN, AMITRIPTYLINE, OXYCONTIN, PANTOPRAZOLE, NILSTAT, COLOXYL WITH SENNA. Patient died.

Cerezyme Side Effects Report #5671593-1
Physician from JAPAN reported CEREZYME problem on Mar 04, 2008. Male patient, weighting 6.61 lb, was diagnosed with gaucher's disease and was treated with CEREZYME. After drug was administered, patient experienced the following problems/side effects: disease progression, multi-organ failure, nervous system disorder, . CEREZYME dosage: unknown. During the same period patient was treated with DOPAMINE. Patient died on 03/02/2008.

Revlimid Side Effects Report #5671680-8
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 10, 2008. Male patient, 80 years of age, was diagnosed with myelofibrosis and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, myelofibrosis, . REVLIMID dosage: 5 MG, 1 IN D, ORAL. Patient died on 02/04/2008.

Arimidex Side Effects Report #5673108-0
Consumer or non-health professional from BRAZIL reported ARIMIDEX problem on Mar 12, 2008. Female patient, 55 years of age, weighting 132.3 lb, was diagnosed with breast cancer, hypertension, hypercholesterolaemia and was treated with ARIMIDEX. After drug was administered, patient experienced the following problems/side effects: disease progression, . ARIMIDEX dosage: unknown. During the same period patient was treated with ARADOIS H, LIPITOR. Patient recovered.

Neoral Side Effects Report #5674157-9
NEORAL problem was reported by a Health Professional from UNITED STATES on Mar 10, 2008. Male patient, 54 years of age, weighting 154.3 lb, was diagnosed with liver transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: disease progression, dyspnoea, fatigue, haematocrit decreased, haemoglobin decreased, neutropenia, pancytopenia, platelet count decreased, somnolence, . NEORAL dosage: 0.5MG QAM / 1MG QPM. During the same period patient was treated with VALCYTE, MYFORTIC. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5675862-0
Physician from UNITED STATES reported REVLIMID problem on Mar 12, 2008. Female patient, 53 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, multiple myeloma, . REVLIMID dosage: unknown. Patient died on 03/03/2008.

Revlimid Side Effects Report #5675870-X
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 12, 2008. Male patient, 52 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, multiple myeloma, myalgia, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL; 20 MG, 2 IN 1 D, ORAL. Patient died on 07/01/2007.

Aldurazyme Side Effects Report #5675952-2
Health Professional from UNITED STATES reported ALDURAZYME problem on Mar 05, 2008. Female patient, child 11 years of age, weighting 44.09 lb, was diagnosed with mucopolysaccharidosis and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: disease progression, mucopolysaccharidosis i, . ALDURAZYME dosage: 14.5 MG, 1X/W, INTRAVENOUS. Patient recovered.

Bevacizumab Side Effects Report #5675958-3
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 12, 2008. Male patient, weighting 166.0 lb, was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: disease progression, malignant neoplasm progression, . BEVACIZUMAB dosage: 5 MG/KG, Q2W. During the same period patient was treated with ALTACE, PLAVIX, ASPIRIN, LOPRESSOR, HYDROCHLOROTHIAZIDE, VYTORIN, OXALIPLATIN. Patient died on 08/25/2007.

Sutent Side Effects Report #5676343-0
Consumer or non-health professional from PERU reported SUTENT problem on Mar 11, 2008. Male patient, 46 years of age, was diagnosed with renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: disease progression, renal cell carcinoma, . SUTENT dosage: unknown. Patient died on 02/17/2008.

Ranibizumab Side Effects Report #5676436-8
RANIBIZUMAB problem was reported by a Physician from SWITZERLAND on Mar 10, 2008. Female patient, weighting 141.1 lb, was treated with RANIBIZUMAB. After drug was administered, patient experienced the following problems/side effects: disease progression, hypertension, . RANIBIZUMAB dosage: 0.5 MG, UNK. Patient recovered.

Climara Side Effects Report #5676837-8
Consumer or non-health professional from UNITED STATES reported CLIMARA problem on Feb 21, 2008. Female patient, 65 years of age, weighting 158.7 lb, was diagnosed with gastric ulcer and was treated with CLIMARA. After drug was administered, patient experienced the following problems/side effects: disease progression, hot flush, night sweats, . CLIMARA dosage: unknown. During the same period patient was treated with TRANSDERMAL NOS, DIOVAN, NEXIUM. Patient recovered.

Erlotinib Side Effects Report #5676878-0
ERLOTINIB problem was reported by a Physician from JAPAN on Mar 04, 2008. Male patient, 75 years of age, was diagnosed with lung adenocarcinoma and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: disease progression, hypoxia, . ERLOTINIB dosage: 150 MG QD ORAL. During the same period patient was treated with DECADRON, POLYFUL, EURODIN, FAMOTIDINE, DOMPERIDONE, GASMOTIN, MAGNESIUM OXIDE. Patient recovered.

Neoral Side Effects Report #5677012-3
Health Professional from UNITED STATES reported NEORAL problem on Mar 14, 2008. Male patient, 54 years of age, weighting 154.3 lb, was diagnosed with liver transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: disease progression, dyspnoea, fatigue, haematocrit decreased, haemoglobin decreased, neutropenia, pancytopenia, platelet count decreased, somnolence, . NEORAL dosage: 0.5MG QAM / 1MG QPM. During the same period patient was treated with VALCYTE, MYFORTIC. Patient was hospitalized. Patient recovered.

Coviro Side Effects Report #5677264-X
COVIRO problem was reported by a Pharmacist from UNITED STATES on Mar 21, 2008. Male patient, 35 years of age, weighting 99.21 lb, was diagnosed with hiv infection and was treated with COVIRO. After drug was administered, patient experienced the following problems/side effects: disease progression, headache, meningitis cryptococcal, nephropathy toxic, renal failure acute, vomiting, . COVIRO dosage: 300/60 MG DAILY ORAL. During the same period patient was treated with VIRAMUNE, AKURIT, AMPHOTERICIN B. Patient died on 02/22/2008.

Doxorubicin Side Effects Report #5677271-7
Consumer or non-health professional from FRANCE reported DOXORUBICIN problem on Mar 12, 2008. Female patient, 77 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: disease progression, hepatic encephalopathy, hepatic failure, hepatitis b virus, . DOXORUBICIN dosage: unknown. During the same period patient was treated with VINCRISTINE, PREDNISONE, CYCLOPHOSPHAMIDE, RITUXIMAB, VALACYCLOVIR, BACTRIM. Patient was hospitalized. Patient died.

Saizen Side Effects Report #5677920-3
SAIZEN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 07, 2008. Female patient, child 11 years of age, weighting 66.00 lb, was diagnosed with growth hormone deficiency and was treated with SAIZEN. After drug was administered, patient experienced the following problems/side effects: disease progression, scoliosis, . SAIZEN dosage: unknown. Patient recovered.

Tysabri Side Effects Report #5677971-9
Health Professional from UNITED STATES reported TYSABRI problem on Mar 05, 2008. Male patient, 62 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: disease progression, multiple sclerosis, respiratory failure, . TYSABRI dosage: 300 MG;QM;IV. Patient died on 01/01/2008.

Velcade Side Effects Report #5678126-4
VELCADE problem was reported by a Physician from JAPAN on Mar 10, 2008. Female patient, 59 years of age, weighting 123.5 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: disease progression, hepatic function abnormal, hepatic neoplasm, leukaemia, multiple myeloma, petechiae, platelet count decreased, pleural effusion, pneumonia, . VELCADE dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ALLOPURINOL, ASPIRIN, METHYCOBAL, MAGNESIUM OXIDE, RED BLOOD CELLS, PLATELETS. Patient was hospitalized. Patient died on 10/03/2007.

Tracleer Side Effects Report #5678203-8
Health Professional from NETHERLANDS reported TRACLEER problem on Mar 06, 2008. Female patient, 69 years of age, was diagnosed with skin ulcer and was treated with TRACLEER. After drug was administered, patient experienced the following problems/side effects: disease progression, extremity necrosis, skin ulcer, . TRACLEER dosage: 62.5 MG, BID, ORAL. During the same period patient was treated with CALCIUM CHANNEL BLOCKERS, IBUPROFEN, ANTIBIOTICS. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5678216-6
REVLIMID problem was reported by a Pharmacist from UNITED STATES on Mar 24, 2008. Female patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, interstitial lung disease, thrombocytopenia, . REVLIMID dosage: 25MG DAILY 21D/28D PO. During the same period patient was treated with DEXAMETHASONE, OMEPRAZOLE, CIPRO, AREDIA. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5678405-0
Consumer or non-health professional from GERMANY reported MEMANTINE problem on Mar 06, 2008. Female patient, 72 years of age, was diagnosed with open angle glaucoma and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: disease progression, glaucoma, pancreatitis, . MEMANTINE dosage: 10 MG QD PO. During the same period patient was treated with AVANDIA, HYDROCODONE, GLIPIZIDE, ALTACE, METOPROLOL TARTRATE, HYDROCHLOROTHIAZIDE, ASPIRIN, DOCUSATE. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5678689-9
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 17, 2008. Male patient, 63 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, multiple myeloma, . REVLIMID dosage: 10-5MG, DAILY, ORAL. Patient died.

Velcade Side Effects Report #5679494-X
Physician from JAPAN reported VELCADE problem on Mar 13, 2008. Female patient, 46 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: disease progression, herpes zoster, platelet count decreased, . VELCADE dosage: 1.90 MG/M2,INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, DECADRON, BICARBONATE, ALENDRONATE, BAKTAR, FAMOTIDINE, OXYCONTIN, ALLOPURINOL. Patient died on 03/01/2008.

Velcade Side Effects Report #5679620-2
VELCADE problem was reported by a Physician from CROATIA (local name: Hrvatska) on Mar 11, 2008. Female patient, child 1 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: disease progression, sepsis, thrombocytopenia, . VELCADE dosage: unknown. Patient died.

Revlimid Side Effects Report #5679672-X
Physician from UNITED STATES reported REVLIMID problem on Mar 17, 2008. Female patient, 55 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, . REVLIMID dosage: 25 MG, QD, ORAL. Patient died.

Myozyme Side Effects Report #5679718-9
MYOZYME problem was reported by a Physician from AUSTRALIA on Mar 07, 2008. Female patient, 63 years of age, weighting 132.3 lb, was diagnosed with glycogen storage disease type ii and was treated with MYOZYME. After drug was administered, patient experienced the following problems/side effects: disease progression, pneumonia aspiration, . MYOZYME dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Lexapro Side Effects Report #5679751-7
Physician from UNITED STATES reported LEXAPRO problem on Mar 14, 2008. Female patient, 60 years of age, was diagnosed with anxiety, depression and was treated with LEXAPRO. After drug was administered, patient experienced the following problems/side effects: disease progression, fall, hereditary spastic paraplegia, . LEXAPRO dosage: 20 MG QD PO. During the same period patient was treated with POSAMAX, TOPRANIL. Patient recovered.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about DISEASE PROGRESSION side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about DISEASE PROGRESSION